Stay updated on Efficacy of OBE2109 in Uterine Fibroids Clinical Trial
Sign up to get notified when there's something new on the Efficacy of OBE2109 in Uterine Fibroids Clinical Trial page.

Latest updates to the Efficacy of OBE2109 in Uterine Fibroids Clinical Trial page
- Check6 days agoChange DetectedThe page’s displayed revision/version number is updated from **v3.5.2** to **v3.5.3**, reflecting a minor platform or release update rather than any change to the study content.SummaryDifference0.0%

- Check14 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check42 days agoChange DetectedRevision: v3.5.0 added; v3.4.3 removed.SummaryDifference0.0%

- Check49 days agoChange Detected- Removed the term 'Uterine leiomyoma' and the Genetic and Rare Diseases Information Center resources from the page.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded the term 'Uterine leiomyoma' to related topics and included the 'Genetic and Rare Diseases Information Center' as a resources entry.SummaryDifference0.1%

Stay in the know with updates to Efficacy of OBE2109 in Uterine Fibroids Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of OBE2109 in Uterine Fibroids Clinical Trial page.